Health, research ethics and privacy-sensitive computing
Health and life-science research can have substantial value, but it also demands particularly strong privacy, clinical and ethical boundaries. BTG's architecture could support arrangements where a qualified calculation runs against permitted information inside an institution, returning only authorized outputs rather than copying identifiable patient records into an open exchange.
A hospital research team may evaluate a method for detecting a pattern in de-identified measurements under a research agreement. The source data remains in controlled storage. A DataChip represents the relevant calculation. ENTITY records the permitted project and users. ADAM enforces the approved purpose, and BTDU retains appropriate technical evidence and lineage. A commercial partner does not thereby receive the right to view every patient record or use the method as a clinical diagnostic.
Clinical usefulness, regulatory status, informed consent and institutional review are separate questions. The presence of a Rights Passport or passing software tests does not establish clinical safety. The system's value is the possibility of precise, auditable cooperation without a rule that all knowledge must move into one central company database.